Tumor necrosis factor-alpha converting enzyme

Implications for ocular inflammatory diseases

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Tumor necrosis factor-alpha (TNF-α) converting enzyme (TACE), a member of the family of metalloproteinase disintegrin proteins, is responsible for the conversion of inactive TNF-α precursor form to active mature form. TNF-α is a pleiotropic cytokine that contributes to cellular immunity and inflammatory response in wide range of inflammatory pathologies. Although a large number of studies indicate the use of TACE inhibitors, which prevents processing of TNF-α as potential therapeutic drugs for the treatment of inflammatory diseases including rheumatoid arthritis, Crohn's disease and cancer, very few studies indicate its use in ocular pathologies. It is still not clearly understood how the TACE-mediated shedding of cytokines and growth factors in various ocular tissues plays a critical role in the cytotoxic signals causing tissue dysfunction and damage leading to blindness. Regulation of TACE activity is likely to have wide implications for ocular immunology and inflammatory diseases. Specifically, since anti-TNF-α therapies have been used to prevent ocular inflammatory complications, the use of TACE inhibitors could be a novel therapeutic approach for ocular inflammatory diseases especially uveitis.

Original languageEnglish (US)
Pages (from-to)1076-1079
Number of pages4
JournalInternational Journal of Biochemistry and Cell Biology
Volume42
Issue number7
DOIs
StatePublished - Jul 2010

Fingerprint

Eye Diseases
Tumor Necrosis Factor-alpha
Pathology
Enzymes
Immunology
Tissue
Cytokines
Disintegrins
Uveitis
Metalloproteases
Blindness
Allergy and Immunology
Cellular Immunity
Crohn Disease
Rheumatoid Arthritis
Intercellular Signaling Peptides and Proteins
Therapeutics
ADAM17 Protein
Processing
Pharmaceutical Preparations

Keywords

  • Eye
  • Inflammation
  • TACE
  • TNF-alpha
  • Uveitis

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Medicine(all)

Cite this

@article{782811404458480c8626b9812705577a,
title = "Tumor necrosis factor-alpha converting enzyme: Implications for ocular inflammatory diseases",
abstract = "Tumor necrosis factor-alpha (TNF-α) converting enzyme (TACE), a member of the family of metalloproteinase disintegrin proteins, is responsible for the conversion of inactive TNF-α precursor form to active mature form. TNF-α is a pleiotropic cytokine that contributes to cellular immunity and inflammatory response in wide range of inflammatory pathologies. Although a large number of studies indicate the use of TACE inhibitors, which prevents processing of TNF-α as potential therapeutic drugs for the treatment of inflammatory diseases including rheumatoid arthritis, Crohn's disease and cancer, very few studies indicate its use in ocular pathologies. It is still not clearly understood how the TACE-mediated shedding of cytokines and growth factors in various ocular tissues plays a critical role in the cytotoxic signals causing tissue dysfunction and damage leading to blindness. Regulation of TACE activity is likely to have wide implications for ocular immunology and inflammatory diseases. Specifically, since anti-TNF-α therapies have been used to prevent ocular inflammatory complications, the use of TACE inhibitors could be a novel therapeutic approach for ocular inflammatory diseases especially uveitis.",
keywords = "Eye, Inflammation, TACE, TNF-alpha, Uveitis",
author = "Kota Ramana",
year = "2010",
month = "7",
doi = "10.1016/j.biocel.2010.03.011",
language = "English (US)",
volume = "42",
pages = "1076--1079",
journal = "International Journal of Biochemistry and Cell Biology",
issn = "1357-2725",
publisher = "Elsevier Limited",
number = "7",

}

TY - JOUR

T1 - Tumor necrosis factor-alpha converting enzyme

T2 - Implications for ocular inflammatory diseases

AU - Ramana, Kota

PY - 2010/7

Y1 - 2010/7

N2 - Tumor necrosis factor-alpha (TNF-α) converting enzyme (TACE), a member of the family of metalloproteinase disintegrin proteins, is responsible for the conversion of inactive TNF-α precursor form to active mature form. TNF-α is a pleiotropic cytokine that contributes to cellular immunity and inflammatory response in wide range of inflammatory pathologies. Although a large number of studies indicate the use of TACE inhibitors, which prevents processing of TNF-α as potential therapeutic drugs for the treatment of inflammatory diseases including rheumatoid arthritis, Crohn's disease and cancer, very few studies indicate its use in ocular pathologies. It is still not clearly understood how the TACE-mediated shedding of cytokines and growth factors in various ocular tissues plays a critical role in the cytotoxic signals causing tissue dysfunction and damage leading to blindness. Regulation of TACE activity is likely to have wide implications for ocular immunology and inflammatory diseases. Specifically, since anti-TNF-α therapies have been used to prevent ocular inflammatory complications, the use of TACE inhibitors could be a novel therapeutic approach for ocular inflammatory diseases especially uveitis.

AB - Tumor necrosis factor-alpha (TNF-α) converting enzyme (TACE), a member of the family of metalloproteinase disintegrin proteins, is responsible for the conversion of inactive TNF-α precursor form to active mature form. TNF-α is a pleiotropic cytokine that contributes to cellular immunity and inflammatory response in wide range of inflammatory pathologies. Although a large number of studies indicate the use of TACE inhibitors, which prevents processing of TNF-α as potential therapeutic drugs for the treatment of inflammatory diseases including rheumatoid arthritis, Crohn's disease and cancer, very few studies indicate its use in ocular pathologies. It is still not clearly understood how the TACE-mediated shedding of cytokines and growth factors in various ocular tissues plays a critical role in the cytotoxic signals causing tissue dysfunction and damage leading to blindness. Regulation of TACE activity is likely to have wide implications for ocular immunology and inflammatory diseases. Specifically, since anti-TNF-α therapies have been used to prevent ocular inflammatory complications, the use of TACE inhibitors could be a novel therapeutic approach for ocular inflammatory diseases especially uveitis.

KW - Eye

KW - Inflammation

KW - TACE

KW - TNF-alpha

KW - Uveitis

UR - http://www.scopus.com/inward/record.url?scp=77953537922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953537922&partnerID=8YFLogxK

U2 - 10.1016/j.biocel.2010.03.011

DO - 10.1016/j.biocel.2010.03.011

M3 - Article

VL - 42

SP - 1076

EP - 1079

JO - International Journal of Biochemistry and Cell Biology

JF - International Journal of Biochemistry and Cell Biology

SN - 1357-2725

IS - 7

ER -